Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003086392 | SCV003482503 | uncertain significance | Multiple gastrointestinal atresias | 2022-03-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with TTC7A-related conditions. This variant is present in population databases (rs757012029, gnomAD 0.04%). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 327 of the TTC7A protein (p.Pro327Thr). |
Ambry Genetics | RCV003086391 | SCV003579054 | uncertain significance | Inborn genetic diseases | 2021-09-09 | criteria provided, single submitter | clinical testing | The c.979C>A (p.P327T) alteration is located in exon 7 (coding exon 7) of the TTC7A gene. This alteration results from a C to A substitution at nucleotide position 979, causing the proline (P) at amino acid position 327 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |